GSK's US CMO appointed acting GM of Australian business

Arvind Hickman
By Arvind Hickman | 12 January 2018
Theresa Agnew, left, will take over as acting GM of GSK Australia and NZ from Elizabeth Reynolds.

GlaxoSmithKline (GSK) has appointed its top US marketer to serve as acting area general manager of its Australia and New Zealand operations, AdNews can reveal.

Theresa Agnew, the chief marketing officer and vice president of US marketing, will take over the reins as acting GM of GSK’s ANZ business in a month from Elizabeth Reynolds, who has been on “extended personal leave” for several months.

GSK has not publicly revealed the appointment, but has privately begun informing partners and its supply chain of the move.

Agnew has been GSK’s North America CMO for the past four years and has previously headed marketing at several Johnson & Johnson healthcare companies, including McNeil Consumer Healthcare and LifeScan, according to her LinkedIn profile.

She also spent a year as healthcare strategy lead for advertising agency DDB.

Agnew is well respected in US healthcare circles and was recently chosen as the sector’s leading influencers in Medical Media and Marketing’s annual top 50 list.

A GSK spokesperson confirmed Agnew’s appointment but could not provide further details on the length of her tenure.

Have something to say on this? Share your views in the comments section below. Or if you have a news story or tip-off, drop us a line at adnews@yaffa.com.au

Sign up to the AdNews newsletter, like us on Facebook or follow us on Twitter for breaking stories and campaigns throughout the day.

Read more about these related brands, agencies and people

comments powered by Disqus